Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,899 public trials 2,122 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

NCT04929041

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 169 locations
View Trial Details
Active, not recruiting

A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

NCT06487559

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Beijing Youan Hospital, Capital Medical University -No differernce with previous /ID# 261928 Beijing, Beijing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University /ID# 262443 Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center /ID# 262092 Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University /ID# 262091 Guangzhou, Guangdong, China
View Trial Details
Active, not recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, not recruiting

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

NCT01266642

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UF Cancer Center at Orlando Health Orlando, Florida, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Active, not recruiting

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

NCT04736706

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • The University of Alabama at Birmingham ( Site 0010) Birmingham, Alabama, United States
  • UC San Diego ( Site 0050) La Jolla, California, United States
  • Cedars Sinai Medical Center ( Site 0027) Los Angeles, California, United States
  • University of California Irvine ( Site 0029) Orange, California, United States
View all 262 locations
View Trial Details
Active, not recruiting

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

NCT03847428

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Costa Mesa, California, United States
View all 217 locations
View Trial Details

Related conditions